Company Filing History:

6 out of 152

Sanofi-Synthelabo

Years Active: 1986-2005

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6946269 - Alkyl esters of 3-(3,4-dihalophenyl)-2,6-dioxopiperidine-3-propionic acid of use as intermediates (2005-09-20),

2. 6686182 - Alkyl esters of 3-(3,4-dihalophenyl)-2,6-dioxopiperidine-3-propionic acid of use as intermediates (2004-02-03),

3. 6469173 - Alkyl esters of 3-(3,4-dihalogenophenyl)-2,6-dioxopiperidine-3-propionic acid of use as intermediates (2002-10-22),

4. 6417400 - Methyl-phenyl derivatives, preparation method and use (2002-07-09),

5. 6407253 - Method for preparing 4-methyl-biphenyl derivatives (2002-06-18),

6. 6118025 - Method for preparing optically active .alpha.-substituted benzyl alcohols (2000-09-12),

7. 6080875 - Method for preparing 2-thienylethylamine derivatives (2000-06-27),

8. 5420300 - Substituted 2-ethylbenzo [b] thiophene, process for preparation thereof (1995-05-30),

9. 5081240 - Process for the preparation of benzothiazepin-one derivatives (1992-01-14),

10. 5079363 - Process for the preparation of isoquinoline derivatives (1992-01-07),

11. 5071985 - Process for the preparation of morphinane derivatives (1991-12-10),

12. 4831144 - 1H-pyrrolo [3,2-c]pyrrolidines protected in 1-position useful as (1989-05-16),

13. 4625033 - Process for preparing 5-aza-indole and intermediates used in this process (1986-11-25),

Title: The Innovative Journey of Jean-Robert Dormoy

Introduction

Jean-Robert Dormoy, an accomplished inventor based in Sisteron, France, has made significant contributions to the field of chemistry, holding 13 patents to his name. His inventions primarily focus on unique chemical compounds and their applications in various industries. Dormoy's work has allowed for advancements in the development and synthesis of important pharmaceutical intermediates.

Latest Patents

Among his latest innovations are the patents for "Alkyl esters of 3-(3,4-dihalophenyl)-2,6-dioxopiperidine-3-propionic acid." This invention addresses the use of lower-alkyl esters of 3-(3,4-dihalophenyl)-2,6-dioxopiperidine-3-propionic acid derivatives and includes processes for their preparation. These patents highlight Dormoy's commitment to enhancing the efficiency of chemical processes and the production of vital intermediates in pharmaceuticals.

Career Highlights

Throughout his career, Jean-Robert Dormoy has worked with prominent companies in the pharmaceutical industry, including Sanofi-Synthelabo and Sanofi. His experience in these organizations provided him with a robust platform to develop his innovative ideas and conduct extensive research in drug development.

Collaborations

Dormoy's collaborations with esteemed colleagues, such as Alain Heymes and Bertrand Castro, have further enriched his inventive portfolio. Together, they have contributed to various projects that have pushed the boundaries of chemical research, leading to advancements in drug formulations and processes.

Conclusion

Jean-Robert Dormoy's legacy as an inventor is marked by his dedication to innovation and excellence. With 13 patents under his belt and an unwavering commitment to improving chemical processes, he continues to inspire future generations of inventors and researchers in the field. His work exemplifies the importance of creativity and collaboration in driving scientific advancements.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com